Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Overview of the WeARTolerance program. by Ana Beato (20489933)

Subjects:

The image illustrates the five steps of the experiment. by Deborah Ribeiro Frazão (9188152)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

Analytical framework and statistical methods. by Na Chen (153323)

Subjects:

Theoretical frameworks of social protection. by Na Chen (153323)

Subjects:

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

Algorithm operation steps. by Junyan Wang (4738518)

“…However, small object detection faces numerous challenges, such as significant difficulty, substantial interference from complex backgrounds, and inconsistent annotation quality. …”

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

Toroidal metamaterials. by Wen-Ying Zhou (10049543)

Subjects:

Human tissue dielectric parameters. by Wen-Ying Zhou (10049543)

Subjects:

Human head modeling. by Wen-Ying Zhou (10049543)

Subjects:

Variations in SAR for individual organizations. by Wen-Ying Zhou (10049543)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Cohort characteristics. by Vincent Pey (21433304)

Subjects: